Nasdaq Combined Compos (COMPX.US)

Close: 8 540.83 (+61.81), Nov 15, 2019
Automatic technical analysis
Medium term
Recommendation one to six months
Weak Positive

Low risk

Liquidity risk: LowVolatility risk: Low

Indicators 

Rising trend

Trend floor at 7743.62 (-9.3%).
Trend ceiling at 8715.73 (+2.0%).
Annualized rate of increase 12%.

Neutral volume balance

VolBal22: -7

Strong positive momentum

RSI21: 73

Analyses


Short

Medium

Long

Overall

Automatic technical analysis. Medium term, Nov 15, 2019

Nasdaq Combined Composite Index shows strong development within a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 8150 points. The short term momentum of the index is strongly positive, with RSI above 70. This indicates increasing optimism among investors and further price increase for Nasdaq Combined Composite Index. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 43)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.83%2 018.82+0.73%
5 days-14.752.74%1 868.53+0.77%
22 days-7.447.29%1 845.44+5.13%
66 days-22.9114.47%1 773.65+9.86%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Candlesticks 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Short term
Short term: Weak Positive
chart Nasdaq Combined Composite Index (COMPX) Medium term
Medium term: Weak Positive
chart Nasdaq Combined Composite Index (COMPX) Long term
Long term: Weak Positive




 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now